US equities
|
GOOGL
$285.50
▼-12.12%
GOOG
$283.47
▼-11.94%
MSFT
$526.02
▼-0.94%
MU
$954.34
▼-2.94%
AMZN
$246.24
▼-3.28%
NVDA
$213.53
▼-0.86%
META
$623.31
▲+1.77%
AAPL
$349.84
▲+1.75%
GOOGL
$285.50
▼-12.12%
GOOG
$283.47
▼-11.94%
MSFT
$526.02
▼-0.94%
MU
$954.34
▼-2.94%
AMZN
$246.24
▼-3.28%
NVDA
$213.53
▼-0.86%
META
$623.31
▲+1.77%
AAPL
$349.84
▲+1.75%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Institutional Review Board
Recent news which mentions Institutional Review Board
Cybin Moves Forward With Phase 1/2a Clinical Trial For Treatment Of Major Depressive Disorder
June 10, 2022
Tickers
CYBN
Tags
Market News
Markets
Clinilabs Drug Development Corporation
From
Benzinga